Literature DB >> 20197136

The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant.

Wangxue Chen1, Rhonda Kuolee, Hongbin Yan.   

Abstract

3', 5'-Cyclic diguanylic acid (c-di-GMP) is a bacterial intracellular signaling molecule that plays a crucial role in the regulation of bacterial motility, adhesion, cell-to-cell communication, exopolysaccharide synthesis, biofilm formation and virulence. The recent finding that c-di-GMP can act as a danger signal on eukaryotic cells has prompted the study of the immunostimulatory and immunomodulatory properties of c-di-GMP in an effort to determine whether c-di-GMP might be further developed as a potential vaccine adjuvant. In this review, we discussed the recent in vitro and in vivo studies of the immunostimulatory properties of c-di-GMP and the progress that has been made in the preclinical development of c-di-GMP as a potential vaccine adjuvant for systemic and mucosal vaccination. Crown Copyright 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20197136     DOI: 10.1016/j.vaccine.2010.02.081

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  39 in total

1.  Structural and biochemical characterization of linear dinucleotide analogues bound to the c-di-GMP-I aptamer.

Authors:  Kathryn D Smith; Sarah V Lipchock; Scott A Strobel
Journal:  Biochemistry       Date:  2011-12-27       Impact factor: 3.162

2.  Listeria monocytogenes strain-specific impairment of the TetR regulator underlies the drastic increase in cyclic di-AMP secretion and beta interferon-inducing ability.

Authors:  Takeshi Yamamoto; Hideki Hara; Kohsuke Tsuchiya; Shunsuke Sakai; Rendong Fang; Motohiro Matsuura; Takamasa Nomura; Fumihiko Sato; Masao Mitsuyama; Ikuo Kawamura
Journal:  Infect Immun       Date:  2012-04-16       Impact factor: 3.441

Review 3.  Modulating immunity as a therapy for bacterial infections.

Authors:  Robert E W Hancock; Anastasia Nijnik; Dana J Philpott
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

Review 4.  Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination.

Authors:  Christophe J Desmet; Ken J Ishii
Journal:  Nat Rev Immunol       Date:  2012-06-22       Impact factor: 53.106

5.  The structural basis for the sensing and binding of cyclic di-GMP by STING.

Authors:  Yi-He Huang; Xiang-Yu Liu; Xiao-Xia Du; Zheng-Fan Jiang; Xiao-Dong Su
Journal:  Nat Struct Mol Biol       Date:  2012-06-24       Impact factor: 15.369

6.  Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.

Authors:  Melissa C Hanson; Monica P Crespo; Wuhbet Abraham; Kelly D Moynihan; Gregory L Szeto; Stephanie H Chen; Mariane B Melo; Stefanie Mueller; Darrell J Irvine
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

7.  Differential radial capillary action of ligand assay for high-throughput detection of protein-metabolite interactions.

Authors:  Kevin G Roelofs; Jingxin Wang; Herman O Sintim; Vincent T Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

Review 8.  Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants.

Authors:  Thomas W Dubensky; David B Kanne; Meredith L Leong
Journal:  Ther Adv Vaccines       Date:  2013-11

Review 9.  Beyond empiricism: informing vaccine development through innate immunity research.

Authors:  Stuart M Levitz; Douglas T Golenbock
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

10.  Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells.

Authors:  Chih-Hang Anthony Tang; Joseph A Zundell; Sujeewa Ranatunga; Cindy Lin; Yulia Nefedova; Juan R Del Valle; Chih-Chi Andrew Hu
Journal:  Cancer Res       Date:  2016-03-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.